Scorpion Therapeutics Company
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.
Connections from
Headquarters:
Boston, Massachusetts, United States
Funding Status:
Early Stage Venture
Founded Date:
2020-01-01
Last Funding Type:
Series B
Employee Number:
11-50
Total Funding:
270000000
Industry:
P4 Medicine